Editorial: Regorafenib Plus Nivolumab in Advanced Hepatocellular Carcinoma-A Step Toward Mechanism-Guided Second-Line Therapy.
Saved in:
| Title: | Editorial: Regorafenib Plus Nivolumab in Advanced Hepatocellular Carcinoma-A Step Toward Mechanism-Guided Second-Line Therapy. |
|---|---|
| Authors: | Kuo YH; Division of Hepatogastroenterology, Department of Internal Medicine, Kaohsiung Chang Gung Memorial Hospital and Chang Gung University College of Medicine, Kaohsiung, Taiwan., Hung CH; Division of Hepatogastroenterology, Department of Internal Medicine, Kaohsiung Chang Gung Memorial Hospital and Chang Gung University College of Medicine, Kaohsiung, Taiwan. |
| Source: | Alimentary pharmacology & therapeutics [Aliment Pharmacol Ther] 2026 Mar 17. Date of Electronic Publication: 2026 Mar 17. |
| Publication Type: | Editorial |
| Journal Info: | Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 8707234 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1365-2036 (Electronic) Linking ISSN: 02692813 NLM ISO Abbreviation: Aliment Pharmacol Ther Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| ISSN: | 1365-2036 |
|---|---|
| DOI: | 10.1111/apt.70604 |
